Table of Contents Table of Contents
Previous Page  36 / 58 Next Page
Information
Show Menu
Previous Page 36 / 58 Next Page
Page Background

Pamrevlumab: anti-CTGF (connective tissue growth factor) mAb

Resection 45% vs 17%

Carrier E, et al. ESMO 2017